Elucidation of the mechanism in the regulation of chondrocyte-specific Runx2 enhancer and development of the drug for osteoarthritis
Description: We elucidated that a transcription factor Runx2 regulates the proliferation of osteoblast progenitor cells and their commitment to osteoblast-lineage cells through the induction of hedgehog, Fgf, Wnt, Pthlh signaling pathway genes, that Runx2 is required for the transdifferentiation of chondrocytes to osteoblasts, and that Runx2 regulates the expression of major bone matrix protein genes in osteoblasts. We also revealed that Osteocalcin, which expression is regulated by Runx2, aligns the apatite crystals parallel to collagen fibrils but it does not function as a hormone, although it was reported as a hormone. Runx2 is an essential transcription factor for chondrocyte maturation. We identified chondrocyte-specific enhancers in Runx2 genome locus and clarified the mechanism of the chondrocyte-specific expression.
Amount: ¥193,400,000
Funding type: research
Funder scheme: Grant-in-Aid for Scientific Research (S)
Start date: 2018-06-11
End date: 2023-03-31
Investigator: Toshihisa Komori (lead)
Institution: Nagasaki University
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 23
Funder award ID: 18H05283
OpenAlex ID: G1215132772
